World Inborn Gene or Chromosome Alterations Tests Medical Devices Pipeline Assessment Report 2020 – ResearchAndMarkets.com | Financial Buzz

World Inborn Gene or Chromosome Alterations Tests Medical Devices Pipeline Assessment Report 2020 – ResearchAndMarkets.com

The “Inborn Gene or Chromosome Alterations Tests – Medical Devices Pipeline Assessment, 2020” report has been added to ResearchAndMarkets.com’s offering.

“Inborn Gene or Chromosome Alterations Tests – Medical Devices Pipeline Assessment, 2020” provides comprehensive information about the Inborn Gene or Chromosome Alterations Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inborn Gene or Chromosome Alterations Tests are the genetic tests used to detect monogenetic disorders (like Cystic Fibrosis, Haemochromatosis, Prothrombin Mutation etc), polygenetic disorders (like Asthma , Atherosclerosis, Diabetes, Hypertension, Osteoporosis, etc), chromosomal disorders (like Down’s Syndrome, Edwards Syndrome etc), polymorphisms (like HLA-Typing etc).

Scope

  • Extensive coverage of the Inborn Gene or Chromosome Alterations Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inborn Gene or Chromosome Alterations Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inborn Gene or Chromosome Alterations Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2.1 Inborn Gene or Chromosome Alterations Overview

3 Products under Development

3.1 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development

3.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Territory

3.3 Inborn Gene or Chromosome Alterations – Pipeline Products by Regulatory Path

3.4 Inborn Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date

3.5 Inborn Gene or Chromosome Alterations – Ongoing Clinical Trials

4 Inborn Gene or Chromosome Alterations – Pipeline Products under Development by Companies

4.1 Inborn Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development

4.2 Inborn Gene or Chromosome Alterations – Pipeline Products by Stage of Development

5 Inborn Gene or Chromosome Alterations Companies and Product Overview

6 Inborn Gene or Chromosome Alterations- Recent Developments

7 Appendix

Companies Mentioned

  • Aarhus University
  • AbaStar MDx Inc
  • AC-Gen Reading Life S.L.
  • Agena Bioscience Inc
  • Alexion Pharmaceuticals Inc
  • Allele Diagnostics Inc
  • Amarantus Bioscience Holdings Inc
  • Amity University
  • Arrayit Corporation
  • Asuragen Inc
  • Augusta University
  • AutoGenomics Inc
  • Baylor College of Medicine
  • BioCeps (Inactive)
  • Biocept Inc
  • Biofidelity Ltd
  • Boston Children’s Hospital
  • Cardiff Oncology Inc
  • CareDx Inc
  • Celula Inc
  • Children’s Hospital of Philadelphia
  • China Medical Technologies Inc (Inactive)
  • ChipCare Corp
  • ChromaCode Inc
  • Chronix Biomedical Inc
  • Cincinnati Children’s Hospital Medical Center
  • Columbia University
  • Consejo Superior de Investigaciones Cientificas
  • Daan Gene Co Ltd
  • Decipher GenX, Inc.
  • Duke University
  • Echelon Diagnostics Inc
  • EGIS Pharmaceuticals Plc
  • Eone Diagnomics Genome Center Co Ltd
  • Epinex Diagnostics Inc
  • Fina Biotech SL
  • Firalis SAS
  • Fluidigm Corp
  • Fraunhofer Institute for Cell Therapy and Immunology
  • Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV
  • Fred Hutchinson Cancer Research Center
  • French National Institute of Health and Medical Research
  • genedrive plc
  • Genentech USA Inc
  • Genisphere LLC
  • Genomic Vision SA
  • genomiQa Pty Ltd
  • German Cancer Research Center
  • German Institute of Human Nutrition
  • Gilupi GmbH
  • GnuBIO Inc
  • Hadassah Medical Center
  • Hebrew University of Jerusalem
  • Helicos BioSciences Corporation
  • Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
  • Hummingbird Diagnostics GmbH
  • iGene Laboratory Pte Ltd
  • Illumina Inc
  • Indiana University
  • Interpace Biosciences Inc
  • iXlayer Inc
  • Johns Hopkins University
  • JS Genetics Inc
  • Juneau Biosciences LLC
  • KellBenx Inc (Inactive)
  • Laboratory Corp of America Holdings
  • Laval University
  • LifeCodexx AG
  • LineaGen Inc
  • Lucid Diagnostics Inc
  • Maastricht University Medical Center
  • Massachusetts Eye and Ear Infirmary
  • Max Delbruck Center for Molecular Medicine
  • McGill University
  • Medical Research Council
  • MeMed Diagnostics LTD
  • Myriad Genetics Inc
  • Nanosphere Inc
  • National Jewish Health
  • National University of Singapore
  • Nel ASA
  • NewGene Ltd
  • NIPD Genetics
  • Oxford Biodynamics Plc
  • Oxford Gene Technology Ltd
  • ParagonDx LLC (Inactive)
  • PerkinElmer Inc
  • Population Bio Inc
  • Precipio Inc
  • PreCyte, Inc.
  • PredictImmune Ltd
  • Predictive Therapeutics LLC
  • Predigen Inc
  • Progenity Inc
  • Proove BioScience Inc
  • Quest Diagnostics Inc
  • Roche Diagnostics International Ltd
  • Sapien Biosciences
  • Scipher Medicine Corp
  • Seattle Children’s Hospital
  • Seegene Inc
  • Sequenom Inc
  • Sheba Medical Center
  • SkylineDx BV
  • Sophia Genetics SA
  • StellarGene Technologies Pvt Ltd
  • Strand Life Sciences Pvt Ltd
  • SUNY Upstate Medical University
  • Takeda Pharmaceuticals International AG
  • TAmiRNA GmbH
  • TBG Diagnostics Ltd
  • Tel Aviv University
  • The Francis Crick Institute Ltd
  • thromboDx
  • Transplant Genomics Inc
  • Tufts Medical Center
  • University Hospital of Cologne
  • University of Arizona
  • University of California San Diego
  • University of California San Francisco
  • University of Cambridge
  • University of Cape Town
  • University of Central Florida
  • University of Colorado
  • University of Illinois at Chicago
  • University of Melbourne
  • University of Michigan
  • University of Oxford
  • University of Pennsylvania
  • University of Pittsburgh
  • University of Turku
  • Vanadis Diagnostics AB
  • Vanderbilt University
  • Vanessa Research Inc
  • Virginia Commonwealth University
  • VitaPath Genetics, Inc.
  • Yale University

For more information about this report visit https://www.researchandmarkets.com/r/t9idzs

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!